Concepedia

GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

Franco Locatelli, Daria Pagliara, Maria Antonietta De Ioris, Marco Becilli, Giada Del Baldo, Annalisa Serra, Angela Mastronuzzi, Maria Giuseppina Cefalo, Giuseppina Li Pira, Giovanna Leone,

Nature Medicine · 2025 · 37 citations · 30 references

DOI

Concepts

References

30

Current concepts in the diagnosis and management of cytokine release syndrome

Daniel W. Lee, Rebecca Gardner, David Porter et al. · Blood · 2014 · 2.8K citations

, , +14

A note on quantifying follow-up in studies of failure time

M. Schemper, Terry L. Smith · Controlled Clinical Trials · 1996 · 2.5K citations

, , +7

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Chrystal U. Louis, Barbara Savoldo, Gianpietro Dotti et al. · Blood · 2011 · 1.2K citations · Full text

, , +14

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana et al. · New England Journal of Medicine · 2023 · 533 citations

, , +8

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Andras Heczey, Chrystal U. Louis, Barbara Savoldo et al. · Molecular Therapy · 2017 · 530 citations · Full text

, , +14